Doug Schenkel
Stock Analyst at Wolfe Research
(2.89)
# 1,514
Out of 5,124 analysts
70
Total ratings
53.85%
Success rate
33.61%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $47.11 | +27.36% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $379.83 | +26.37% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $102.14 | -26.57% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $26.98 | +18.61% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $59.05 | +1.61% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $74.49 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $31.72 | +89.16% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $20.12 | +39.17% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $275.14 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $163.86 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $3.25 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $228.92 | +24.50% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $136.07 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $44.97 | +14.52% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $16.31 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $131.16 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $101.56 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $579.45 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.15 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $96.75 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.87 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $11.46 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $229.09 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.67 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.49 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.95 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.25 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.83 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $20.15 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.63 | +1,004.29% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $21.98 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $284.24 | -68.34% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.36 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $185.56 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $66.37 | -75.89% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $47.11
Upside: +27.36%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $379.83
Upside: +26.37%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $102.14
Upside: -26.57%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $26.98
Upside: +18.61%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $59.05
Upside: +1.61%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $74.49
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $31.72
Upside: +89.16%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $20.12
Upside: +39.17%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $275.14
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $163.86
Upside: -
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.25
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $228.92
Upside: +24.50%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $136.07
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $44.97
Upside: +14.52%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $16.31
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $131.16
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $101.56
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $579.45
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $6.15
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $96.75
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.87
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $11.46
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $229.09
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.67
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.49
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.95
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.25
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.83
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $20.15
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.63
Upside: +1,004.29%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $21.98
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $284.24
Upside: -68.34%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $6.36
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $185.56
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $66.37
Upside: -75.89%